Tag: Eric Schneiderman
HRC Hails NY AG Schneiderman For Investigating NFL Policies After Discriminatory Incident
The Human Rights Campaign, America’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organisation today joined New York Attorney General Eric Schneiderman in calling on the NFL to explain and address deeply disturbing reports that some prospective players are being asked inappropriate questions about their sexual orientation.
After Turing Pharmaceuticals’ Outrageous Price Hike on Life-Saving Drug, Low-Cost Alternative Emerge
Express Scripts and Imprimis Pharmaceuticals announce partnership for low-cost alternative in response to unconscionable decision from Martin Shkreli’s Turing Pharmaceuticals to continue price hike on Daraprim.
HRC Slams Ridiculous Announcement that Turing Pharmaceuticals will “Roll Back” Price on Daraprim
Making no commitments, Shkreli says life-saving treatment will still cost at least $375, more than 2,500 percent higher than the original Daraprim price.
New York Attorney General Answers HRC’s Call, Launches Inquiry Into Turing Pharmaceuticals
Today, at the urging of the Human Rights Campaign (HRC), the New York attorney general has begun investigating whether Turing Pharmaceuticals, which recently imposed an unconscionable 5000 percent price hike on the life-saving drug Daraprim, may have violated antitrust laws by limiting its distribution. Chad Griffin, President of HRC, America’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organisation, released the following statement:
The Clock Is Ticking: 14 Days Since Turing CEO Promised to Roll Back Price Hike
HRC calls on Turing Chief Martin Shkreli to fulfil his pledge.
HRC Calls on NY Attorney General to Investigate Turing Pharmaceuticals’ Exploitative Price Gouging
Today, the Human Rights Campaign, (HRC), America’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organisation sent a letter to New York Attorney General Eric Schneiderman asking him to investigate recent actions by New York-based Turing Pharmaceuticals to increase the price of the drug Daraprim (pyrimethamine) by 5000 percent.